Market Overview

Benzinga's Top Upgrades

Benzinga's Top Upgrades
Related TEVA
Don't Worry Spec. Pharma Investors, Drug Pricing Legislation Probably Won't Affect You
Benzinga's M&A Chatter for Thursday October 1, 2015
'Overdue' Dividend Increases (And Other Streaks In Peril) (Seeking Alpha)
Related JASO
For The Patient Investor, Future Looks Bright For Solar ETFs
Morning Market Gainers
SolarCity's Threats Are Not A Huge Problem For Chinese Solar Companies (Seeking Alpha)

Analysts at Morgan Stanley upgraded Teva Pharmaceutical Industries (NYSE: TEVA) from “underweight” to “equal-weight.” The price target for Teva Pharmaceutical is set to $52. Teva Pharmaceutical's shares closed at $47.96 yesterday.

Axiom upgraded JA Solar Holdings Co (NASDAQ: JASO) from “undefined” to “buy.” The price target for JA Solar is set to $16. JA Solar's shares closed at $10.55 yesterday.

Analysts at Keefe Bruyette & Woods upgraded Independent Bank (NASDAQ: INDB) from “market perform” to “outperform.” The price target for Independent Bank has been raised from $40 to $44. Independent Bank's shares closed at $38.11 yesterday.

Oppenheimer upgraded Lowe's Companies (NYSE: LOW) from “market perform” to “outperform.” The price target for Lowe's Companies has been raised from $50 to $57. Lowe's shares closed at $48.71 yesterday.

Latest Ratings for TEVA

Sep 2015NomuraInitiates Coverage onNeutral
Aug 2015Goldman SachsReinstatesBuy
Aug 2015JP MorganUpgradesNeutralOverweight

View More Analyst Ratings for TEVA
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings


Related Articles (INDB + JASO)

View Comments and Join the Discussion!

Get Benzinga's Newsletters